Type 2 Diabetes: What's new in the RACGP guidelines?
RACGP
6 episodes
1 week ago
The updated Royal Australian College of General Practitioners (RACGP) guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence. Across six webinars, contributors to the guidelines, Dr Gary Deed (GP), and Michelle Robins (nurse practitioner and credentialled diabetes educator) are joined by Dr Tom Dover (endocrinologist) to discuss key updates as they share their unique insights and practical guidance on the management of type 2 diabetes.
This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi.
Sanofi‐Aventis Australia Pty Ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101753 Date of preparation August 2021
All content for Type 2 Diabetes: What's new in the RACGP guidelines? is the property of RACGP and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The updated Royal Australian College of General Practitioners (RACGP) guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence. Across six webinars, contributors to the guidelines, Dr Gary Deed (GP), and Michelle Robins (nurse practitioner and credentialled diabetes educator) are joined by Dr Tom Dover (endocrinologist) to discuss key updates as they share their unique insights and practical guidance on the management of type 2 diabetes.
This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi.
Sanofi‐Aventis Australia Pty Ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101753 Date of preparation August 2021
Type 2 Diabetes: What's new in the RACGP guidelines?
The updated Royal Australian College of General Practitioners (RACGP) guidelines on the management of type 2 diabetes is an important primary care tool that provides GPs and other health professionals with information and recommendations based on the latest body of evidence. Across six webinars, contributors to the guidelines, Dr Gary Deed (GP), and Michelle Robins (nurse practitioner and credentialled diabetes educator) are joined by Dr Tom Dover (endocrinologist) to discuss key updates as they share their unique insights and practical guidance on the management of type 2 diabetes.
This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi.
Sanofi‐Aventis Australia Pty Ltd trading as Sanofi Genzyme. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101753 Date of preparation August 2021
